- Home
- CYCC vs DVLT Comparison
CYCC vs DVLT Comparison
Compare CYCC & DVLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CYCC
- DVLT
- Stock Information
- Founded
- CYCC 1992
- DVLT 2010
- Country
- CYCC Malaysia
- DVLT United States
- Employees
- CYCC N/A
- DVLT N/A
- Industry
- CYCC Biotechnology: Pharmaceutical Preparations
- DVLT
- Sector
- CYCC Health Care
- DVLT
- Exchange
- CYCC Nasdaq
- DVLT NYSE
- Market Cap
- CYCC 61.2M
- DVLT 55.7M
- IPO Year
- CYCC N/A
- DVLT N/A
- Fundamental
- Price
- CYCC $0.35
- DVLT $0.72
- Analyst Decision
- CYCC
- DVLT Strong Buy
- Analyst Count
- CYCC 0
- DVLT 1
- Target Price
- CYCC N/A
- DVLT $3.00
- AVG Volume (30 Days)
- CYCC 3.6M
- DVLT 399.6K
- Earning Date
- CYCC 08-13-2025
- DVLT 08-13-2025
- Dividend Yield
- CYCC 41.68%
- DVLT N/A
- EPS Growth
- CYCC N/A
- DVLT N/A
- EPS
- CYCC N/A
- DVLT N/A
- Revenue
- CYCC $14,000.00
- DVLT $3,048,000.00
- Revenue This Year
- CYCC $137.21
- DVLT $434.03
- Revenue Next Year
- CYCC N/A
- DVLT $221.43
- P/E Ratio
- CYCC N/A
- DVLT N/A
- Revenue Growth
- CYCC N/A
- DVLT 63.08
- 52 Week Low
- CYCC $0.25
- DVLT $0.60
- 52 Week High
- CYCC $39.84
- DVLT $3.34
- Technical
- Relative Strength Index (RSI)
- CYCC 25.10
- DVLT N/A
- Support Level
- CYCC $0.29
- DVLT N/A
- Resistance Level
- CYCC $0.46
- DVLT N/A
- Average True Range (ATR)
- CYCC 0.19
- DVLT 0.00
- MACD
- CYCC 0.05
- DVLT 0.00
- Stochastic Oscillator
- CYCC 6.33
- DVLT 0.00
About CYCC Cyclacel Pharmaceuticals Inc.
Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases. The company develops several families of anticancer drugs that act on the cell cycle, including CDK (cyclin-dependent kinase) inhibitors and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include fadraciclib and plogosertib.
About DVLT DATAVAULT AI INC
Datavault AI Inc is a data technology and licensing company that enables clients and strategic partners to monetize their Blockchain Data and AI Web 3.0 assets via tokenization, data ownership and digital twins offering two solutions: Data Science licenses High-Performance Computing (HPC) software applications and Web 3.0 data management serving the biotech, energy, education, fintech, real estate, and healthcare industries, among others. Acoustic Science licenses spatial and multichannel HD sound transmission, including proprietary brands ADIO, WiSA and Sumerian, to customers in sports & entertainment, events & venues, restaurants, automotive, finance, and other industries.